Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Henry Ford Health

Status: Withdrawn

Conditions: Phototherapy

Treatments: Other: narrowband UVB phototherapy; Other: LED phototherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT01818154

7257

Details and patient eligibility

About

The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.

Sex: All

Ages: 18 to 120 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Age greater than 18 years.

Exclusion criteria

1. Pregnancy
2. Lactation
3. History of photosensitivity disorder
4. Photosensitizing medications
5. Personal history of melanoma or non-melanoma skin cancer.
6. Skin disease on the back

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups, including a placebo group

Minimal Erythema Dose LED

Experimental group

Description:

A 2 x 2 cm section of skin will be exposed to LED light.

Treatment:

Other: narrowband UVB phototherapy

Other: LED phototherapy

Minimal Erythema Dose narrow band UVB

Placebo Comparator group

Description:

A 2 x 2 cm section of skin will be exposed to narrow band UVB light.

Treatment:

Other: narrowband UVB phototherapy

Other: LED phototherapy